Prof. Nagy Habib is an internationally renowned HPB surgeon and Professor at Imperial College London with over three decades of experience in cancer research and surgery. He pioneered clinical trials in gene therapy for liver cancer and developed innovative technologies including the Habib 4X surgical device. Prof. Habib is the founder of MiNA Therapeutics and currently serves as CEO of Apterna Limited, focusing on RNA-based therapies and translational oncology research.
Join Congress 2026